Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Group-Based Exercise Intervention to Prevent Cognitive and Motor Decline

NCT07494149 · tracked via the Priya Life Science Italy tracker
Sponsor
University of Bergamo
Phase
Not applicable
Started
2026-02-01
Last updated
2026-03-27

Condition(s) studied

HealthyOlder Adults

Investigational drug(s) / intervention(s)

IdeomotorControl

Ideomotor: The Ideomotor Program sessions will include the following: 1. Warm-up Light-intensity physical-cognitive exercises. 2. Work-out 1 Mind-Motor: Stimulates physical and cognitive abilities through functional exercises. 3. Work-out 2 3.1) Mind-Motor: stimulate physical and cognitive abilities through aerobic exercises (once a week) 3.2) Work-out 2 Motor only: high-velocity muscle power exercises (once a week). 4. Cool-down: light-intensity walking or dynamic stretching combined with breathing 5. Socialization: dedicated moment to encourage socialization. Participants' feedback will be received once a month.

Control: The Group-based cognitive training will include the following: 1. Warm-up: cognitive exercises designed for training basic cognitive abilities in adults and older adults; 2. Work-out: cognitive exercises designed for training complex cognitive abilities in adults and older adults; 3. Cool-down: moment for discussion of the exercises and their possible solutions; 4. Socialization: dedicated moment to encourage socialization. Participants' feedback will be received once a month.

Study summary

The goal of this clinical trial is to evaluate the efficacy of the Ideomotor Program in healthy older adults living in the community. The main research questions are:

1\) Is the Ideomotor Program effective in improving cognitive function? 2) Is the Ideomotor Program effective in improving motor function? 3) Is the Ideomotor Program effective in improving overall well-being?

Researchers will compare the Ideomotor Program to a community group cognitive training program to determine whether the effects are superior. Participants will: undergo assessments at baseline, at the mid-intervention point, and upon program completion; participate in a 16-week group exercise program in a community gym two times per week; keep a diary to monitor the number of falls and any adverse events.

Eligibility

Sex
ALL
Min age
50 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * At least 50 years old; * Able to move independently; * Live in the community; * Demonstrated ability to comprehend complex verbal instructions. Exclusion Criteria: * Presence of severe neurological and psychological conditions; * Less than 9,36 score in the FAB15; * Lack of medical clearance to participate in an exercise program; * Less than 75% of attendance.

Primary outcome measure(s)

  • Executive functions — At baseline and at the end of the intervention period (week 17)
    The Frontal Assessment Battery-15 will be used to access changes from baseline in executive functions (score range: 0-15, higher scores mean a better outcome)
  • Cognitive flexibility — At baseline and at the end of the intervention period (week 17)
    Wisconsin Card Sorting Test will be used to assess changes from baseline in cognitive flexibility (score range perseverative errors: 0-64, higher scores mean a worse outcome)
  • Short-term and working memory — At baseline and at the end of the intervention period (week 17)
    The Digit span test (forward and backward) will be used to assess from baseline changes in short-term and working memory (foward score range: 3-9, backward score range: 3-8; higher scores mean a better outcome)
  • Visuo-spatial short term working memory — At baseline and at the end of the intervention period (week 17)
    The Corsi Block-Tapping Test will be used to assess changes from baseline in visuo-spatial short term working memory (score range: 2-9, higher scores mean a better outcome)

Trial sites (2)

FacilityCityRegionStatus
Centre for Healthy Longevity Bergamo Bergamo Recruiting
University of Bergamo - S. Agostino Bergamo BG Not Yet Recruiting

More University of Bergamo trials in Italy

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07494149 on ClinicalTrials.gov ↗ ← All trials in Italy